Cargando…
Evaluation of vitamin B(6) supplementation in Wilson’s disease patients treated with D-penicillamine
INTRODUCTION: Wilson’s disease (WD) is a copper metabolism disorder characterised by a progressive accumulation of this metal mainly in the liver and the brain. Treatment is based on the removal of copper operated by the chelators, among which, D-penicillamine (DP) is prescribed as a first-line trea...
Autores principales: | Mbala, Justin, Belmalih, Abdelouahed, Guillaud, Olivier, Lachaux, Alain, Couchonnal Bedoya, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476132/ https://www.ncbi.nlm.nih.gov/pubmed/37652551 http://dx.doi.org/10.1136/bmjgast-2023-001211 |
Ejemplares similares
-
Wilson Disease and Alpha1-Antitrypsin Deficiency: A Review of Non-Invasive Diagnostic Tests
por: Guillaud, Olivier, et al.
Publicado: (2023) -
D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
por: Goh, Yihui, et al.
Publicado: (2021) -
A rare case of DIC in a patient with Wilson’s disease: D-penicillamine
por: Emre Parlar, Yavuz, et al.
Publicado: (2022) -
D-penicillamine Induced Myasthenia Gravis in Wilson’s Disease: A Case Report
por: Thapa, Lekhjung, et al.
Publicado: (2022) -
Pompholyx-Like Eruptions Induced by Penicillamine in a Patient with Wilson's Disease
por: Devassy, Diana Elizabeth, et al.
Publicado: (2019)